Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Mesoblast, Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Virginia Commonwealth University